Axogen Inc vs iShares MSCI Australia ETF — how do they compare? Axogen Inc trades at $48.3 (market cap $2.61B), while iShares MSCI Australia ETF trades at $30.02. Which is the better fit depends on your goals.
| AXGN | EWA | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $48.48 | $30.41 |
52-Week Low | $14.16 | $24.95 |
Enterprise Value | $2.52B | — |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →